Beelen D W, Neumann M C, Mahmoud H K, Henneberg K, Thraenhart O, Schaefer U W
Immun Infekt. 1985 Sep;13(5):229-32.
Nineteen bone marrow transplant recipients had cytomegalovirus prophylaxis using a commercial hyperimmune globulin. Seronegative donors were selected for blood component substitution. The incidence of seroconversion was 25%. One patient acquired fatal cytomegalovirus associated interstitial pneumonitis. The value of this combined cytomegalovirus prophylaxis in bone marrow transplant recipients in comparison to sole passive immunization is recommended to be the subject of a controlled trial.
19名骨髓移植受者使用市售高效价免疫球蛋白进行巨细胞病毒预防。选择血清阴性供者进行血液成分置换。血清转化发生率为25%。1例患者发生致命的巨细胞病毒相关性间质性肺炎。与单纯被动免疫相比,这种联合巨细胞病毒预防措施在骨髓移植受者中的价值建议作为对照试验的主题。